Search results - 619 results

Herpes zoster in Belgium: a new solution to an old problem

clinical trials that has since been confirmed in real-world effectiveness studies. In clinical trials, protection was sustained for at least 10 years after vaccination. As of 1 November 2023, RZV is ...

Belgian National Burden of Disease Study. Patterns of tobacco use and sales in Belgium: a critical appraisal of available data sources

Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Sarah Nayani; Leonor Guariguata; Brecht Devleesschauwer Source: Sciensano, Brussels, Belgium, p.30 (2024) Accession Number: D/2023.14.440/81 Keywords: burden of dise ...

Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.

Disease virus (NDV)) fusion protein (F) as an rHVT- H9-F vaccine, is an alternative to currently used classical vaccines. This study investigated H9- and ND-specific humoral and mucosal responses, ...

EBoD-FL. Guidelines for mapping the environmental burden of disease in Flanders, 2023

risks. Environmental burden of disease (EBD) studies try to estimate the impact of environmental stressors in terms mortality or morbidity on a population level. Although environmental risks have been ...

Challenges in Chlamydial Serology: Insights from a Belgian and a Dutch Population Cohort.

serology is invaluable. Multiple studies, nonetheless, indicate deficiencies in specificity and sensitivity of current chlamydial antibody detection assays. Incorporation of multiple antigens per target is ...

Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules.

sensitive areas could be a complementary measure to the disease control strategies already applied. In this study, the efficacy of a novel DNA vaccine, encoding a H5 gene (A/gyrfalcon/Washington/41088-6/2014 ...

Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.

for ONT R10. This study provides a proof of concept for using ONT R10, either in isolation or in combination with Illumina, for rapid and accurate bacterial SNP-based outbreak investigation. Health ...

Closing the gap: Oxford Nanopore Technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens.

for ONT R10. This study provides a proof of concept for using ONT R10, either in isolation or in combination with Illumina, for rapid and accurate bacterial SNP-based outbreak investigation. Health ...

QR code

QR code for this page URL